The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Kliuchareva S.V.

Mechnikov North-Western State Medical University, Saint Petersburg, Russia

Ivanov R.A.

National Medical Research Center for Children’s Health, Moscow, Russia

Pyoderma in the outpatient practice of a dermatovenereologist-cosmetologist: current issues and modern approaches to effective therapy (a series of clinical cases)

Authors:

Kliuchareva S.V., Ivanov R.A.

More about the authors

Journal: Russian Journal of Clinical Dermatology and Venereology. 2026;25(2): 260‑270

DOI: 10.17116/klinderma202625021260

Read: 393 times

Contact the author
Table of contents

PYODERMA IN THE OUTPATIENT PRACTICE OF A DERMATOVENEREOLOGIST-COSMETOLOGIST: CURRENT ISSUES AND MODERN APPROACHES TO EFFECTIVE THERAPY (A SERIES OF CLINICAL CASES)
PYODERMA IN THE OUTPATIENT PRACTICE OF A DERMATOVENEREOLOGIST-COSMETOLOGIST: CURRENT ISSUES AND MODERN APPROACHES TO EFFECTIVE THERAPY (A SERIES OF CLINICAL CASES)

To cite this article:

Kliuchareva SV, Ivanov RA. Pyoderma in the outpatient practice of a dermatovenereologist-cosmetologist: current issues and modern approaches to effective therapy (a series of clinical cases). Russian Journal of Clinical Dermatology and Venereology. 2026;25(2):260‑270. (In Russ.)
https://doi.org/10.17116/klinderma202625021260

Подписка 2026 Клиническая дерматология и венерология (Russian Journal of Clinical Dermatology and Venereology)
МСФ на ЯМ
Использование инфографики авторами научных работ
Recommended articles:
Clinical case of nevoid hype­rkeratosis of the nipple-areola complex. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(4):537-540
Clinical prospects of passive ultrasonic disi­nfection in endo­dontic practice. Stomatology. 2026;(2):65-70
Abstract:

Pyoderma remains one of the most common causes for patient visit in outpatient practice of dermatovenereologists and cosmetologists due to its clinical polymorphism, tendency to recurrence and the risk of developing cosmetic defects. At the same time, there are difficulties in making decision on which particular antibacterial drug to use as an empirical therapy. The urgency of the problem is emphasized by growing antibiotic resistance, comorbidities associated with impaired skin barrier and increased patient aesthetic expectations. Within the frame of the article, modern approaches to treatment with a focus on rational choice of topical antibacterial agents are considered. Comprehensive analysis of literature and own clinical experience aimed at assessing the effectiveness, safety and resistance profile of the main topical antibacterial drugs used in outpatient dermatological practice was carried out. The presented data and a review of clinical cases demonstrate that personalized management of patients with consideration of the characteristics of the infectious process course can increase the effectiveness of treatment, reduce the recurrence rate and improve clinical and aesthetic outcomes. Currently, in pediatric and adult patients, the leading role is assigned to a hydrophilic mupirocin 2% ointment, which can be used as a combination treatment with modern antiseptic solutions and systemic antibacterial agents, if necessary, to ensure high clinical effectiveness and contribute to a significant reduction in the duration of therapy.

Keywords:

pyoderma
skin and soft tissue infections (SSTI)
methicillin-resistant Staphylococcus aureus (MRSA)
mupirocin
topical therapy
biofilm

Authors:

Kliuchareva S.V.

Mechnikov North-Western State Medical University, Saint Petersburg, Russia

Ivanov R.A.

National Medical Research Center for Children’s Health, Moscow, Russia

Received:

19.02.2026

Accepted:

22.03.2026

Close metadata

References:

  1. Dermatovenerologiya. Natsional’noe rukovodstvo. Skripkin YuK, Butov YuS, Ivanov OL, eds. M. 2014:319-356. (In Russ.).
  2. Kozhnye i venericheskie bolezni. Ivanov OL, ed. M. 2006:83-97. (In Russ.).
  3. Elkin VD, Mitryukovsky LS, Sedova TG. Izbrannaya dermatologiya. Redkie dermatozy i dermatologicheskie sindromy. Perm; 2004. (In Russ.).
  4. Guo H, Zheng P. Epidemiological trends and disparities in the global burden of bacterial skin diseases among children and adolescents from 1990 to 2021: an analysis based on GBD 2021. BMC Pediatr. 2025 Jun 09;25(1):467. PMID: 40490714; PMCID: PMC12147331. https://doi.org/10.1186/s12887-025-05825-z
  5. Wilkinson JD. Fusidic acid in dermatology. Br J Dermatol. 1998;139(53):37-40. PMID: 9990411. https://doi.org/10.1046/j.1365-2133.1998.1390s3037.x
  6. Sobye P. [Cutaneous Staphylococcus aureus infection treated with fucidin ointment]. Ugeskr Laeger. 1966;128(7):204-206. (In Danish).
  7. Grice EA, Kong HH, Conlan S, Deming CB, Davis J, Young AC. Topographical and temporal diversity of the human skin microbiome. Science. 2009;324(5931):1190-1192. https://doi.org/10.1126/science.1171700
  8. Ibrahim F, Khan T, Pujalte GG. Bacterial Skin Infections. Prim Care. 2015 Dec;42(4):485-499.  https://doi.org/10.1016/j.pop.2015.08.001
  9. Toschi A, Giannella M, Viale P. Recurrence of skin and soft tissue infections: identifying risk factors and treatment strategies. Curr Opin Infect Dis. 2025 Apr 01;38(2):71-77.  https://doi.org/10.1097/QCO.0000000000001096
  10. Rashmi Sarkar, Apaopa Jemima Thekho, Taku Rini. Infectious complications in esthetic dermatology procedures: A narrative review. Journal of Cutaneous and Aesthetic Surgery. 2025;1(8):1  https://doi.org/10.25259/JCAS_198_2025
  11. Mel’nikov VG, Villena J, Kombarova SYu. The problem of decolonization of nasal carriers of Staphylococcus aureus from the point of view of a microbiologist (literature review). Klinicheskaya laboratornaya diagnostika. 2019; 64(11):693-699. (In Russ.).
  12. Zagrtdinova RM, Lyashenko NV, Sergeeva TP, Kobeleva TA, Petrunin DD. Experience in the treatment of bacterial skin infections in children in outpatient practice. Vestnik dermatologii i venerologii. 2024;100(3):58-64. (In Russ.). https://doi.org/10.25208/vdv14866
  13. Samtsov AV, Statsenko AV, Khairutdinov VR, Chaplygin AV. Comparative study of the clinical efficacy of 3% tetracycline ointment and 2% mupirocin ointment in the treatment of pyoderma. Vestnik dermatologii i venerologii. 2012;3:86-90. (In Russ.).
  14. Bash GN, Higgins C, McClanahan D, et al. Atypical cutaneous manifestations of methicillin resistant Staphylococcus aureus infections in two immunocompetent pediatric patients: Case reports and review of the literature. Pediatr Dermatol. 2025 Jan-Feb;42(1):112-117.  https://doi.org/10.1111/pde.15703
  15. Sergeev AYu, Burtseva GN, Sergeeva MA. New concepts and solutions to the problem of staphylococcal infections in dermatology. Immunopatologiya, allergologiya, infektologiya. 2019;3:48-62. (In Russ.).
  16. Abrha S, Tesfaye W, Thomas J. Intolerable Burden of Impetigo in Endemic Settings: A Review of the Current State of Play and Future Directions for Alternative Treatments. Antibiotics. 2020;9(12):909.  https://doi.org/10.3390/antibiotics9120909
  17. Galgano M, Pellegrini F, Catalano E, et al. Acquired Bacterial Resistance to Antibiotics and Resistance Genes: From Past to Future. Antibiotics. 2025; 14(3):222.  https://doi.org/10.3390/antibiotics14030222
  18. Hajikhani B, Goudarzi M, Kakavandi S, et al. The global prevalence of fusidic acid resistance in clinical isolates of Staphylococcus aureus: a systematic review and meta-analysis. Antimicrob Resist Infect Control. 2021 May 01; 10(1):75.  https://doi.org/10.1186/s13756-021-00943-6
  19. Deplano A, Hallin M, Bustos Sierra N, Michel C, Prevost B, Martiny D, Yin N. Persistence of the Staphylococcus aureus epidemic European fusidic acid-resistant impetigo clone (EEFIC) in Belgium. J Antimicrob Chemother. 2023 Aug 02;78(8):2061-2065. https://doi.org/10.1093/jac/dkad204
  20. Vittorakis E, Vica ML, Zervaki CO, et al. A Comparative Analysis of MRSA: Epidemiology and Antibiotic Resistance in Greece and Romania. International Journal of Molecular Sciences. 2024;25(14):7535. https://doi.org/10.3390/ijms25147535
  21. Ana Martins, et al. Antibiotic candidates for Gram-positive bacterial infections induce multidrug resistance. Sci Transl Med. 2025 Jan 08;17(780): eadl2103. https://doi.org/10.1126/scitranslmed.adl2103
  22. Wesgate R, Evangelista C, Atkinson R, et al. Understanding the risk of emerging bacterial resistance to over-the-counter antibiotics in topical sore throat medicines. J Appl Microbiol. 2020 Oct;129(4):916-925.  https://doi.org/10.1111/jam.14682
  23. Gisby J, Bryant J. Efficacy of a new cream formulation of mupirocin: comparison with oral and topical agents in experimental skin infections. Antimicrob Agents Chemother. 2000 Feb;44(2):255-260.  https://doi.org/10.1128/AAC.44.2.255-260.2000
  24. Shivashankar Shilpa Hurkadli, Patil Chidanand, Pala Vinay S. Evaluation of the Relationship Between Biofilm Production, Antimicrobial Susceptibility and Methicillin-resistance in Staphylococcus aureus Isolates; A Systematic Review. Medical Journal of Dr. D.Y. Patil Vidyapeeth. 2025 Mar-Apr; 18(2):178-186.  https://doi.org/10.4103/mjdrdypu.mjdrdypu_317_24
  25. Gonzalez T, Stevens ML, Baatyrbek Kyzy A, et al. Biofilm propensity of Staphylococcus aureus skin isolates is associated with increased atopic dermatitis severity and barrier dysfunction in the MPAACH pediatric cohort. Allergy. 2021 Jan;76(1):302-313.  https://doi.org/10.1111/all.14489
  26. Murashkin NN, Gluzmin MI, Skoblikov NE, et al. The role of methicillin-resistant strains of Staphylococcus aureus in the pathogenesis of severe forms of atopic dermatitis in childhood. Ways to achieve remission. Vestnik dermatologii i venerologii. 2012;88(1):66-74. (In Russ.). https://doi.org/10.25208/vdv652
  27. Romo-González C, Aquino-Andrade A, et al. Antimicrobial Susceptibility Patterns and Biofilm Formation of Staphylococcus aureus Strains Isolated from Pediatric Patients with Atopic Dermatitis. Microorganisms. 2026; 14(2):311.  https://doi.org/10.3390/microorganisms14020311
  28. Roy S, Santra S, Das A, Dixith S, et al. Staphylococcus aureus Biofilm Infection Compromises Wound Healing by Causing Deficiencies in Granulation Tissue Collagen. Ann Surg. 2020 Jun;271(6):1174-1185. https://doi.org/10.1097/SLA.0000000000003053
  29. Almuhanna Y. Microbial Biofilms as Barriers to Chronic Wound Healing: Diagnostic Challenges and Therapeutic Advances. Journal of Clinical Medicine. 2025;14(22):8121. https://doi.org/10.3390/jcm14228121
  30. Bel’kova YuA. Pyoderma in outpatient practice. Diseases and pathogens. Klinicheskaya mikrobiologiya i antimikrobnaya khimioterapiya: 2005;3(7): 255-270. (In Russ.).
  31. Fernandes P. Fusidic Acid: A Bacterial Elongation Factor Inhibitor for the Oral Treatment of Acute and Chronic Staphylococcal Infections. Cold Spring Harb Perspect Med. 2016 Jan 4;6(1):a025437. https://doi.org/10.1101/cshperspect.a025437
  32. Samtsov AV. Topical therapy of pyoderma. Vestnik dermatologii i venerologii. 2020;96(5):59-64. (In Russ.). https://doi.org/10.25208/vdv1167-2020-96-5-59-64
  33. Chain EB, Mellows G. Pseudomonic acid. Part I. The structure of pseudomonic acid A, a novel antibiotic produced by Pseudomonas fluorescens. J Chem Soc Perkin Transactions. 1977;1:294-309. 
  34. Hughes J, Mellows G. Inhibition of isoleuciyl-transfer ribonucleic acid synthetase in Escherichia coli by pseudomonic acid. Biochem J. 1978;176:305-318. 
  35. Hughes J, Mellows G. On the mode of action of pseudomonic acid: inhibition of protein synthesis in Staphylococcus aureus. J Antibiot. 1978;31:330-335. 
  36. Pappa KA. The clinical development of mupirocin J Amer Acad Dermatol. 1990;22:873¬879. 
  37. Sutherland R, Boon RJ, Griffin KE. Antibacterial activity of mupirocin (pseudomonic acid), a new antibiotic for topical use. Antimicrob Agent Chemother. 1985;27:495-498. 
  38. Langdon CG, Mahapatra KS. Efficacy and acceptability of fusidic acid cream and mupirocin ointment in acute skin sepsis. Current Ther Research 1990;48:174-179. 
  39. Jasuja K, Gupta S, Arora D, Gupta V. Bacteriology of primary pyodermas and comparative efficacy of topical application of mupirocin and sodium fusidate ointments in their treatment. Indian J Dermatol Venereol Leprol. 2001;67(3):132-134. 
  40. Chen E, Shaffer MG, Bilodeau RE, et al. Clinical rel mutations in Staphylococcus aureus prime pathogen expansion under nutrient stress. mSphere. 2023 Oct 24;8(5):e0024923. https://doi.org/10.1128/msphere.00249-23
  41. Li B, Qiu Y, Shi H, Yin H. The importance of lag time extension in determining bacterial resistance to antibiotics. The Analyst. 2016;141(10):3059-3067. https://doi.org/10.1039/c5an02649k
  42. Araviiskaya ER, Samtsov AV. Treatment of primary pyoderma and chronic dermatoses complicated by secondary infection: choosing an effective drug. Consilium Medicum. 2021;23(8):682-689. (In Russ.).
  43. Altoé LS, Alves RS, Sarandy MM, Morais-Santos M, Novaes RD, Gonçalves RV. Does antibiotic use accelerate or retard cutaneous repair? A systematic review in animal models. PLoS One. 2019 Oct 10;14(10):e0223511. https://doi.org/10.1371/journal.pone.0223511
  44. Twilley D, Reva O, Meyer D, Lall N. Mupirocin Promotes Wound Healing by Stimulating Growth Factor Production and Proliferation of Human Keratinocytes. Front Pharmacol. 2022 Apr 11;13:862112. https://doi.org/10.3389/fphar.2022.862112
  45. Gurel MS, Naycı S, Turgut AV, Bozkurt ER. Comparison of the effects of topical fusidic acid and rifamycin on wound healing in rats. Int Wound J. 2013;12:106-110. pmid:23489386.
  46. Khoshnood S, Heidary M, Asadi A, Soleimani S, Motahar M, Savari M, Saki M, Abdi M. A review on mechanism of action, resistance, synergism, and clinical implications of mupirocin against Staphylococcus aureus. Biomed Pharmacother. 2019 Jan;109:1809-1818. https://doi.org/10.1016/j.biopha.2018.10.131
  47. Bidossi A, Bottagisio M, De Grandi R, Drago L, De Vecchi E. Chlorquinaldol, a topical agent for skin and wound infections: anti-biofilm activity and biofilm-related antimicrobial cross-resistance. Infect Drug Resist. 2019; 12:2177-2189. https://doi.org/10.2147/IDR.S211007
  48. Marquès C, Tasse J, Pracros A, et al. Effects of antibiotics on biofilm and unattached cells of a clinical Staphylococcus aureus isolate from bone and joint infection. J Med Microbiol. 2015 Sep;64(9):1021-1026. https://doi.org/10.1099/jmm.0.000125
  49. Bass JW, Chan DS, Creamer KM, et al. Comparison of oral cephalexin, topical mupirocin and topical bacitracin for treatment of impetigo. Pediatr Infect Dis J. 1997;6(7):708-709. 
  50. Koning S, van der Sande R, Verhagen AP, van Suijlekom-Smit LW, Morris AD, Butler CC, et al. Interventions for impetigo. Cochrane Database Syst Rev. 2012;1(1):CD003261.
  51. Raj A, Jha AK. Efficacy and Safety Profile of Topical 2% Mupirocin Vs Topical 2% Fusidic Acid in the Treatment of Superficial Bacterial Infections. Int J Heal Clin Res. 2021;4:161-163. 
  52. Welsh O, Saenz C. Topical mupirocin compared with oral ampicillin in the treatment of primary and secondary skin infections. Curr Ther Res. 1987;41:114-120. 
  53. Instruktsiya po meditsinskomu primeneniyu preparata Supirotsin, LSR-000592/09 ot 29.01.2009. (In Russ.). Accessed February 16, 2026. https://www.grls.rosmonzdrav.ru
  54. Kreft B, Wohlrab J. Contact allergies to topical antibiotic applications. Allergol Select. 2022 Feb 01;6:18-26.  https://doi.org/10.5414/ALX02253E
  55. Velappan R, Ramasamy S, Venu S, Chandrasekar M. A randomised open label comparative study evaluating the effectiveness, adherence and safety between 2% mupirocin ointment and 2% fusidic acid cream in children with impetigo. Int J Res Dermatol. 2019;5:511-516. 
  56. Ahire K, Wadile R, Pande B, Shejwal D. Mupirocin Resistance Patterns in Staphylococcus Isolates Causing Cutaneous and Soft-Tissue Infections: An Epidemiological Study in a Tertiary Health-Care Facility, Dhule, Maharashtra, India. Asian J Med Sci. 2023;14:195-201. 
  57. Gupta D. Bacterial Skin and Soft Tissue Infections in Children. Pediatr Inf Dis. 2021;3(4):146-155. 
  58. Gupta S. Bacterial Skin Infections. Quick References 2024. https://doi.org/10.1542/aap.ppcqr.396136
  59. Klinicheskie rekomendatsii. Piodermii. 2025. Elektronnyj rubrikator klinicheskikh rekomendatsij. (In Russ.). Accessed February 15, 2026. https://cr.minzdrav.gov.ru/view-cr/232_2
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.